Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05381233
Other study ID # 78093
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 1, 2022
Est. completion date July 15, 2024

Study information

Verified date May 2022
Source October 6 University
Contact emad ismail, doctoral
Phone 01146808839
Email emad9111@live.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Caregiver Burden (CB) is expressed as a multidimensional response related to caregiving, including physical, psychological, emotional, social, and economic problems and has been identified as a public health concern. All these factors negatively affect caregiver health and indirectly affect the care of the disabled child .To provide better support for parents of children with CP, we must understand the difficulties faced those parents and identify the key and common areas where assistance can be rendered.


Description:

The symptoms of CP vary from person to person. A person with severe CP might need to use special equipment to be able to walk, or might not be able to walk at all and might need lifelong care. A person with mild CP, on the other hand, might walk a little awkwardly, but might not need any special help. CP does not get worse over time, though the exact symptoms can change over a person's lifetime.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date July 15, 2024
Est. primary completion date June 1, 2024
Accepts healthy volunteers No
Gender All
Age group 2 Years to 18 Years
Eligibility Inclusion Criteria: - Age older then 18 years. - there BMI will be ranged from 18.5 too 24.9 kg/m2 (Misra et al., 2009) . - They are the main caregiver for there children. - They are of low or middle socioeconomic status according too socioeconomic status scale (El-Gilany et al., 2012). - Having at least 7months of experience in taking care of the child. - They have no congenital spinal anomalies or lower limb deformities. Exclusion Criteria: - Children wif congenital anomalies and chromosomal disease. - Children wif recent musculoskeletal surgery. - Any associated problems.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Gross motor function classification System (GMFCS)
assessment
Arabic Version of Zarit burden Inventory measure
assessment
Arabic Version of Chalder Fatigue Scale (CFQ version 11)
assessment

Locations

Country Name City State
Egypt Emad Cairo

Sponsors (1)

Lead Sponsor Collaborator
Sara Shawki Mohamed

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Gross motor function classification System (GMFCS) Which are a Standardized method too, classify gross motor function in children with (CP) aged from 2 too, 18years. Teh GMFCS are a 5-level system designed too, reflect differences in gross motor function that are meaningful in teh daily lives of children with CP and there families, with an emphasis on sitting and walking. A classification are made by determining which level best corresponds too, a child"s present gross motor function (Palisano et al., 1997). dis scale will be used for detecting teh CP child functional performance level 3 months
Primary Arabic Version of Zarit burden Inventory measure It are one of the most commonly used measures of caregiver burden (Knight et al., 2000). The care burden of all the participants will be evaluated by the Zarit burden Inventory measures (ZBI). The ZBI assesses the stress suffered by those whom give care too the persons in need. Initially developed and validated more TEMPthan 25 years ago (Zarit et al., 1980) 3 months
See also
  Status Clinical Trial Phase
Recruiting NCT05365698 - Supporting Optimal Infant, Young Child and Maternal Nutrition and Health in Jordan: An Evaluation of the CHN Program
Active, not recruiting NCT03964311 - Risk for Short-term Adverse Events in Older Emergency Department Users N/A
Completed NCT03286660 - 3 Minutes Chair Rise Test (3CRT) in Patients With COPD N/A
Completed NCT03734042 - PRP Intrauterine Infusion in Thawed Embryo Cycles Phase 4